Literature DB >> 26607219

Neck recurrence and mortality in esthesioneuroblastoma: Implications for management of the N0 neck.

James G Naples1, Jeffrey Spiro1, Belachew Tessema2, Clinton Kuwada3, Chia-Ling Kuo4, Seth M Brown2.   

Abstract

OBJECTIVES/HYPOTHESIS: To review the literature on neck recurrence in esthesioneuroblastoma. STUDY
DESIGN: PubMed database.
METHODS: A PubMed database search was performed using keywords "esthesioneuroblastoma," "olfactory neuroblastoma," and "esthesioneuroblastoma neck metastasis." Articles written in English with greater than 10 subjects that had data regarding the association of neck recurrence and mortality and/or the association of neck recurrence with Kadish stage were included for analysis.
RESULTS: Thirteen studies met inclusion criteria with information regarding the association of neck recurrence and mortality, and 15 studies had data associating neck recurrence and Kadish stage. The neck recurrence rate was 14.1% in studies analyzing mortality. Among those patients who developed regional metastases, mortality was 60%. Of patients without regional recurrence, the mortality rate from disease was 26% (P < 0.0001) and overall mortality was 32% (P < 0.0001). The rate of neck recurrence within each Kadish stage was 0%, 11%, 21%, and 18% for Kadish stages A, B, C, and D, respectively. The trend toward an increased incidence of neck recurrence from stage A to stage D is statistically significant, with P value 0.003.
CONCLUSION: The rate of neck recurrence in esthesioneuroblastoma is close to 15%. There is a strong association of recurrence with Kadish stage B and C. Mortality from disease in patients with recurrence in cervical lymph nodes is significant when compared to those who never develop neck disease. Prospective studies are needed to evaluate a potential role for elective neck dissection versus elective neck radiation for patients with esthesioneuroblastoma. LEVEL OF EVIDENCE: N/A. Laryngoscope, 126:1373-1379, 2016.
© 2015 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Esthesioneuroblastoma; Kadish; elective neck treatment; neck recurrence; olfactory neuroblastoma

Mesh:

Year:  2015        PMID: 26607219     DOI: 10.1002/lary.25803

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

1.  Dural Invasion Predicts the Laterality and Development of Neck Metastases in Esthesioneuroblastoma.

Authors:  John P Marinelli; Jeffrey R Janus; Jamie J Van Gompel; Michael J Link; Eric J Moore; Kathryn M Van Abel; Brandon W Peck; Christine M Lohse; Daniel L Price
Journal:  J Neurol Surg B Skull Base       Date:  2018-02-22

2.  Olfactory Neuroblastomas: What Actually Happens in the Long-Term?

Authors:  Konstantinos Mantsopoulos; Michael Koch; Heinrich Iro; Jannis Constantinidis
Journal:  J Clin Med       Date:  2022-04-20       Impact factor: 4.964

3.  Changing Trends in the Management of Esthesioneuroblastoma: Irish and International Perspectives.

Authors:  Robbie S R Woods; Thavakumar Subramaniam; Mary Leader; Rory McConn-Walsh; James Paul O'Neill; Peter D Lacy
Journal:  J Neurol Surg B Skull Base       Date:  2017-11-01

4.  Delaying Postoperative Radiotherapy in Low-Grade Esthesioneuroblastoma: Is It Worth the Wait?

Authors:  Satoshi Kiyofuji; Vijay Agarwal; Joshua D Hughes; Robert L Foote; Jeffrey R Janus; Eric J Moore; Caterina Giannini; Michael J Link; Jamie J Van Gompel
Journal:  J Neurol Surg B Skull Base       Date:  2020-03-25

5.  Recurrent Olfactory Neuroblastoma Treated With Cetuximab and Sunitinib: A Case Report.

Authors:  Lizhi Wang; Yan Ding; Lai Wei; Dewei Zhao; Ruoyu Wang; Yuewei Zhang; Xuesong Gu; Zhiqiang Wang
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.